The active constituent of spironolactone after acute administration in man [proceedings]. (Record no. 7362260)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01118 a2200313 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250513022237.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 198006s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0306-5251 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1111/j.1365-2125.1980.tb04854.x |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | McInnes, G T |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 19800627 |
| 245 00 - TITLE STATEMENT | |
| Title | The active constituent of spironolactone after acute administration in man [proceedings]. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | British journal of clinical pharmacology |
| Date of publication, distribution, etc. | Mar 1980 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 295P-296P p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biotransformation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Spironolactone |
| General subdivision | metabolism |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Asbury, M J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shelton, J R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Harrison, I R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ramsay, L E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Venning, G R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Clarke, J M |
| 773 0# - HOST ITEM ENTRY | |
| Title | British journal of clinical pharmacology |
| Related parts | vol. 9 |
| -- | no. 3 |
| -- | p. 295P-296P |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1111/j.1365-2125.1980.tb04854.x">https://doi.org/10.1111/j.1365-2125.1980.tb04854.x</a> |
| Public note | Available from publisher's website |
No items available.